POGZ Antibody - BSA Free

Immunohistochemistry-Paraffin: POGZ Antibody [NBP1-83004]

Immunohistochemistry-Paraffin: POGZ Antibody [NBP1-83004] - Staining of human placenta shows moderate to strong nuclear positivity in trophoblastic cells.

Immunohistochemistry-Paraffin: POGZ Antibody [NBP1-83004]

Immunohistochemistry-Paraffin: POGZ Antibody [NBP1-83004] - Staining of human rectum shows moderate to strong nuclear positivity in glandular cells.

Chromatin Immunoprecipitation-exo-Seq: POGZ Antibody - BSA Free [NBP1-83004]

ChIP-Exo-Seq composite graph for Anti-POGZ (NBP1-83004) tested in K562 cells. Strand-specific reads (blue: forward, red: reverse) and IgG controls (black: forward, grey: reverse) are plotted against the distance from a composite set of reference binding sites. The antibody exhibits robust target enrichment compared to a non-specific IgG control and precisely reveals its structural organization around the binding site. Data generated by Prof. B. F. Pugh´s Lab at Cornell University.

Western Blot: POGZ Antibody - BSA Free [NBP1-83004] -

POGZ (GenBank accession number: NM_015100.4) de novo missense variants in neuropsychiatric disorders. (a) Frontal and lateral face photos of the proband reported in this study. (b) Sanger sequencing validated the missense variant is de novo. (c) Immunoblot analysis of POGZ expression in peripheral blood lymphocytes of patient and control. Three independent experiments were performed. Data are means +/- SEM. Differences were statistically significant by Student's t‐test (***p <.001). (d) Location distribution of all reported POGZ de novo missense variants. The novel de novo missense variant identified in this study is marked with red color. (e) Conservation analysis of all reported POGZ de novo missense. The new pathogenic de novo missense variant identified in our study is denoted in red color Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/31347273), licensed under a CC-BY license. Not internally tested by Novus Biologicals.